Efficacy of ronidazole for treatment of cats experimentally infected with a Korean isolate of Tritrichomonas foetus.
To evaluate the efficacy of ronidazole for treatment of Tritrichomonas foetus infection, 6 Tritrichomonas-free kittens were experimentally infected with a Korean isolate of T. foetus. The experimental infection was confirmed by direct microscopy, culture, and single-tube nested PCR, and all cats demonstrated trophozoites of T. foetus by day 20 post-infection in the feces. From day 30 after the experimentally induced infection, 3 cats were treated with ronidazole (50 mg/kg twice a day for 14 days) and 3 other cats received placebo. Feces from each cat were tested for the presence of T. foetus by direct smear and culture of rectal swab samples using modified Diamond's medium once a week for 4 weeks. To confirm the culture results, the presence of T. foetus rRNA gene was determined by single-tube nested PCR assay. All 3 cats in the treatment group receiving ronidazole showed negative results for T. foetus infection during 2 weeks of treatment and 4 weeks follow-up by all detection methods used in this study. In contrast, rectal swab samples from cats in the control group were positive for T. foetus continuously throughout the study. The present study indicates that ronidazole is also effective to treat cats infected experimentally with a Korean isolate of T. foetus at a dose of 50 mg/kg twice a day for 14 days.
Laboratory of Veterinary Parasitology, College of Veterinary Medicine, Chonnam National University, Gwangju 500-757, Korea.
Sun
S
Lim
Sang-Ik
SI
Park
Kyu-Sung
KS
Ahn
Dae-Sung
DS
Oh
Sung-Shik
SS
Shin
D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage*; D002371:Cat Diseases / Q000188:drug therapy* / Q000469:parasitology; D002415:Cats; D004195:Disease Models, Animal; D005243:Feces / Q000469:parasitology; D008297:Male; D010274:Parasitology / Q000379:methods; D010919:Placebos / Q000008:administration & dosage; D016133:Polymerase Chain Reaction / Q000379:methods; D011528:Protozoan Infections / Q000188:drug therapy* / Q000469:parasitology; D012385:Ronidazole / Q000008:administration & dosage*; D016896:Treatment Outcome; D016835:Tritrichomonas foetus / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity*
D000981:Antiprotozoal Agents; D010919:Placebos; D012385:Ronidazole